Reservoirneuro
San Francisco, US · Founded 2019 · 2 known investors
Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier. The company operates in the neuroscience drug development space.
Founders & leadership
AF
Aaron FriedmanExecutive
VS
Vladimir SenatorovNamed on SEC filing
Board
TS
Tracy SaxtonBoard director
JS
James SummersBoard director
BS
Brian SlingerlandBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$9M disclosed across 3 rounds · 2021–2026
▶$3MraisedJun 2026 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedJun 2026 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
- Aaron FriedmanExecutive Officer
- James SummersDirector
- Vladimir SenatorovDirector
- Brian SlingerlandDirector
- Offering amount
- $8M
- Amount sold
- $3M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedNov 2023 · 7 investors · BiotechnologyRule 506(b)
▶$2.1MraisedNov 2023 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian SlingerlandDirector
- Vladimir SenatorovExecutive Officer, Director
- Aaron FriedmanExecutive Officer, Director
- Patrick BurgermeisterDirector
- James SummersDirector
- Offering amount
- $4.1M
- Amount sold
- $2.1M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$3.9MraisedAug 2021 · 16 investors · BiotechnologyRule 506(b)
▶$3.9MraisedAug 2021 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Aaron FriedmanExecutive Officer, Director
- Tracy SaxtonDirector
- Brian SlingerlandDirector
- Vladimir SenatorovExecutive Officer, Director
- Offering amount
- $8.8M
- Amount sold
- $3.9M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Reservoirneuro do?
- Reservoir Neuroscience is developing therapeutics aimed at repairing the blood-brain barrier. The company operates in the neuroscience drug development space.
- Who are Reservoirneuro's investors?
- Reservoirneuro's investors include age1, Dolby Family Ventures.
- How much funding has Reservoirneuro raised?
- Reservoirneuro has disclosed $9M raised across 3 rounds.
- Where is Reservoirneuro headquartered?
- Reservoirneuro is headquartered in San Francisco, US.